858 related articles for article (PubMed ID: 19111537)
1. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
Hussein MR; Al-Assiri M; Musalam AO
Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
4. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
5. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
6. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.
Descazeaud A; Weinbreck N; Robert G; Vacherot F; Abbou CC; Labrousse F; Allory Y; Rubin MA; de la Taille A
BJU Int; 2011 Jul; 108(2 Pt 2):E23-8. PubMed ID: 20840324
[TBL] [Abstract][Full Text] [Related]
9. [Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer].
Xiang ST; Zhou SW; Guan W; Wang QZ; Zhang B; Liu JH; Ye ZQ
Zhonghua Nan Ke Xue; 2003 Oct; 9(7):497-500. PubMed ID: 14628595
[TBL] [Abstract][Full Text] [Related]
10. Different perforin expression in peripheral blood and prostate tissue in patients with benign prostatic hyperplasia and prostate cancer.
Tokmadžić VS; Tomaš MI; Sotošek S; Laškarin G; Dominović M; Tulić V; Dorđević G; Sustić A; Mrakovčić-Šutić I
Scand J Immunol; 2011 Oct; 74(4):368-76. PubMed ID: 21535078
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of ubiquitin in human prostate gland.
Bataineh ZM; Habbal O
Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
[TBL] [Abstract][Full Text] [Related]
13. [The distribution of mast cells in benign and malignant prostate lesions and its biologic significance].
Deng WB; Li P; Li GX; Zhao Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):623-5. PubMed ID: 15460402
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi's sarcoma.
Hussein MR
Cell Biol Int; 2008 Jan; 32(1):157-62. PubMed ID: 17950633
[TBL] [Abstract][Full Text] [Related]
15. [Early histopathological aspects of benign prostatic hyperplasia: myxoid-inflammatory nodules].
Manzarbeitia F; Vela Navarrete R; Fernández-Aceñero MJ
Actas Urol Esp; 2010 Jun; 34(6):549-54. PubMed ID: 20510119
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
[TBL] [Abstract][Full Text] [Related]
17. Collagen fibers in human prostatic lesions: histochemistry and anisotropies.
Taboga SR; Vidal Bde C
J Submicrosc Cytol Pathol; 2003 Jan; 35(1):11-6. PubMed ID: 12762646
[TBL] [Abstract][Full Text] [Related]
18. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma.
Chuang AY; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1225-30. PubMed ID: 17667547
[TBL] [Abstract][Full Text] [Related]
19. Benign mimics of prostatic adenocarcinoma on needle biopsy.
Gaudin PB; Reuter VE
Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
[TBL] [Abstract][Full Text] [Related]
20. [Biosynthetic and proliferative characteristics of the prostatic epithelium in nodular hyperplasia, in cancer and in the peritumoral area].
Fedosenko KV
Vopr Onkol; 2002; 48(1):47-9. PubMed ID: 12101565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
